tiprankstipranks
Trending News
More News >
Haemonetics (HAE)
:HAE
US Market

Haemonetics (HAE) Income Statement

Compare
398 Followers

Haemonetics Income Statement

Last quarter (Q4 2025), Haemonetics's total revenue was $330.60M, a decrease of -3.70% from the same quarter last year. In Q4, Haemonetics's net income was $57.98M. See Haemonetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Jun 23Jun 22Jun 21
Total Revenue
$ 1.36B$ 1.31B$ 1.17B$ 993.20M$ 870.46M
Gross Profit
$ 748.96M$ 691.55M$ 615.10M$ 505.50M$ 397.84M
Operating Expenses
$ 527.14M$ 526.66M$ 459.06M$ 433.78M$ 339.88M
Depreciation and Amortization
$ 0.00$ 97.22M$ 93.31M$ 97.75M$ 84.29M
EBITDA
$ 221.82M$ 265.58M$ 249.34M$ 178.50M$ 142.25M
Operating Income
$ 221.82M$ 164.88M$ 156.03M$ 80.75M$ 57.96M
Other Income/Expenses
$ -9.75M$ -54.97M$ -14.63M$ -17.12M$ 14.95M
Pretax Income
$ 212.07M$ 151.87M$ 141.40M$ 63.63M$ 72.91M
Net Income
$ 167.68M$ 117.56M$ 115.40M$ 43.38M$ 79.47M
Per Share Metrics
Basic EPS
$ 3.31$ 2.32$ 2.27$ 0.85$ 1.57
Diluted EPS
$ 3.31$ 2.29$ 2.24$ 0.84$ 1.55
Weighted Average Shares Outstanding
50.33M 50.71M 50.78M 51.05M 50.69M
Weighted Average Shares Outstanding (Diluted)
50.73M 51.40M 51.42M 51.35M 51.29M
Currency in USD

Haemonetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis